Over the past 12 months, Avenue Therapeutics insiders made no open-market purchases or sales of the stock.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Biotech, Inc. Fortress | TenPercentOwner | 453,495 | 0 | 453,495 | 63.9% | 06 Jan, 2026 |
| 2 | Alexandra Maclean | Chief Executive Officer | 170,000 | 0 | 170,000 | 23.9% | 25 Sep, 2024 |
| 3 | David Jin | Interim Pfo And Coo | 65,000 | 0 | 65,000 | 9.2% | 25 Sep, 2024 |
| 4 | Robert L Davidow | TenPercentOwner | 9,078 | 7,182 | 16,260 | 2.3% | 13 Dec, 2023 |
| 5 | Lindsay A Md Rosenwald | Director | 4,723 | 0 | 4,723 | 0.7% | 12 Sep, 2023 |
| 6 | Jay D Kranzler | Director | 559 | 0 | 559 | 0.1% | 07 Nov, 2024 |
| 7 | Neil Herskowitz | Director | 97 | 0 | 97 | 0.0% | 03 Dec, 2024 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 02 Jan, 2026 | Biotech, Inc. Fortress | TenPercentOwner | Acquired A | 111,209 | $0.00 | $0 | 439,733 | Direct |
| 31 Mar, 2025 | Biotech, Inc. Fortress | TenPercentOwner | Acquired A | 33,724 | $0.00 | $0 | 328,524 | Direct |
| 02 Dec, 2024 | Neil Herskowitz | Director | Disposed S | 23 | $2.00 | $46 | 97 | Direct |
| 05 Nov, 2024 | Jay D Kranzler | Director | Disposed S | 61 | $2.24 | $137 | 559 | Direct |
| 27 Sep, 2024 | Jay D Kranzler | Director | Acquired P | 3 | $2.40 | $7 | 123 | Direct |
| 30 Sep, 2024 | Jay D Kranzler | Director | Acquired P | 497 | $2.50 | $1.24K | 620 | Direct |
| 23 Sep, 2024 | Lindsay A Md Rosenwald | Director | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 23 Sep, 2024 | Neil Herskowitz | Director | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 23 Sep, 2024 | Faith L. Charles | Director | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 23 Sep, 2024 | David Jin | Interim Pfo And Coo | Acquired A | 65,000 | $0.00 | $0 | 65,000 | Direct |
| 23 Sep, 2024 | Curtis Gale Oltmans | Director | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 23 Sep, 2024 | Alexandra Maclean | Chief Executive Officer | Acquired A | 170,000 | $0.00 | $0 | 170,000 | Direct |
| 23 Sep, 2024 | Jay D Kranzler | Director | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 16 Apr, 2024 | Biotech, Inc. Fortress | TenPercentOwner | Acquired A | 413,507 | $0.00 | $0 | 47,287 | Direct |
| 02 Jan, 2024 | Biotech, Inc. Fortress | TenPercentOwner | Acquired A | 2,101,496 | $0.00 | $0 | 41,775 | Direct |
| 11 Dec, 2023 | Robert L Davidow | TenPercentOwner | Disposed S | 264,000 | $10.50 | $2.77Mn | 9,078 | Direct |
| 11 Dec, 2023 | Robert L Davidow | TenPercentOwner | Disposed S | 18,000 | $11.25 | $202.55K | 293 | Indirect |
| 11 Dec, 2023 | Robert L Davidow | TenPercentOwner | Disposed S | 61,000 | $10.50 | $640.66K | 986 | Indirect |
| 11 Dec, 2023 | Robert L Davidow | TenPercentOwner | Disposed S | 126,000 | $10.50 | $1.32Mn | 2,877 | Indirect |
| 11 Dec, 2023 | Robert L Davidow | TenPercentOwner | Disposed S | 128,000 | $10.50 | $1.34Mn | 1,960 | Indirect |